Statistics In the Pharmaceutical Industry
Updated and expanded to reflect the recent trends and challenges in pharmaceutical statistics, this third edition presents chapters written by experts from both regulatory agencies and pharmaceutical companies.
janvier 2023, env. 496 pages, Chapman & Hall/CRC Biostatistics Series, Anglais
Taylor and Francis
978-1-03-247787-9
Taylor and Francis
978-1-03-247787-9
Updated and expanded to reflect the recent trends and challenges in pharmaceutical statistics, this third edition presents chapters written by experts from both regulatory agencies and pharmaceutical companies.
janvier 2023, env. 496 pages, Chapman & Hall/CRC Biostatistics Series, Anglais
Taylor and Francis
978-1-03-247787-9
Taylor and Francis
978-1-03-247787-9
Autres titres de la collection: Chapman & Hall/CRC Biostatistics Series
Afficher toutMedical Statistics for Cancer Studies
Taylor and Francis, 2024
978-1-032-28587-0
79.00 CHF
disponible de suite
Statistical Analytics for Health Data Science with SAS and R
Taylor and Francis, 2023
978-1-03-232562-0
env. 140.00 CHF
livrable dans env. 10-20 jours
Bayesian Methods in Health Economics
Taylor and Francis, 2023
978-1-03-247753-4
env. 80.00 CHF
livrable dans env. 10-20 jours
Data Science, AI, and Machine Learning in Drug Development
Taylor and Francis, 2022
978-0-367-70807-8
env. 206.00 CHF
livrable dans env. 10-20 jours
Bayesian Cost-Effectiveness Analysis of Medical Treatments
Taylor and Francis, 2020
978-0-367-73187-8
env. 86.00 CHF
livrable dans env. 10-20 jours
Artificial Intelligence for Drug Development, Precision Medicine, and Healthcare
Taylor and Francis, 2020
978-0-367-36292-8
env. 206.00 CHF
livrable dans env. 10-20 jours
Bayesian Cost-Effectiveness Analysis of Medical Treatments
Taylor and Francis, 2019
978-1-138-73173-8
env. 206.00 CHF
livrable dans env. 10-20 jours
Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement
An Applied Approach Using SAS & STATA
Taylor and Francis, 2015
978-1-4665-0547-6
env. 146.00 CHF
livrable dans env. 10-20 jours
Benefit-Risk Assessment in Pharmaceutical Research and Development
Taylor and Francis, 2013
978-1-4398-6794-5
env. 156.00 CHF
livrable dans env. 10-20 jours
Autres titres sur ce thème
Copula Models for Dependent Competing Risks
Theory and Applications in Economics, Engineering, Medicine
Taylor and Francis, 2026
978-1-032-85121-1
env. 299.00 CHF
paraît en juillet
Decision-Making and Analytics
Data-Driven Business Intelligence and Optimization
Taylor and Francis, 2026
978-1-041-23733-4
env. 159.00 CHF
paraît en juillet
Pharmaceutical Process Engineering
Taylor and Francis, 2026
978-1-032-73011-0
env. 315.00 CHF
paraît en juillet
Derivatives
Mathematical Foundations for Finance Students
Taylor and Francis, 2026
978-1-032-76218-0
env. 99.00 CHF
paraît en juin
Innovative Nanocarriers for Stimulated Drug Delivery
A Comprehensive Guide to Stimuli-responsive Nanoparticles
Elsevier, 2026
978-0-443-33641-6
env. 255.00 CHF
paraît en juin
Variably Legal Markets
Rethinking Markets and Crime
Taylor and Francis, 2026
978-0-367-18613-5
env. 249.00 CHF
paraît en mars
Process Analytical Technology and Data Analysis for the Manufacturing of ...
Taylor and Francis, 2026
978-1-032-66291-6
env. 169.00 CHF
paraît en août
Topical Dermal Drug Delivery
Concepts and Advances
Elsevier, 2026
978-0-443-21945-0
env. 215.00 CHF
paraît en juillet
Sustainable Financial Structured Products
Managing Risk Appetites across Modelling, Structuring, and Hedging
Taylor and Francis, 2026
978-1-032-65887-2
env. 315.00 CHF
paraît en mai
Data Science for Sustainable Development Goals
Indian Case Studies
Taylor and Francis, 2026
978-1-032-78131-0
env. 239.00 CHF
paraît en mai
Advancing Integrative Medicine Through Medical Intelligence
Introduction to Medical Intelligence with Integrative Medicine
Elsevier, 2026
978-0-443-44021-2
env. 225.00 CHF
paraît en août
Financial Enterprise Risk Management
Cambridge Academic, 2026
978-1-009-56555-4
env. 165.00 CHF
paraît en mai